RxDoctor Payments Data

Derek Nickerson, MD

MOHS-Micrographic Surgery · San Diego, CANPI 1265895619

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.7% of the total across 187 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 16.2% — the pattern of someone who eats at a lot of different presentations.

$4,878in general payments, 2019–2025

Across 187 payments — averaging $26.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$791
  • Pfizer$575
  • Sanofi$495
  • Lilly USA, LLC$444
  • Regeneron Healthcare Solutions, Inc.$347
  • Johnson & Johnson$313
  • plus $2K from 17 others

What the payments were for

  • Food & beverage$4,866100%
  • Education$130%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,878 in reported general payments places this provider in the 65th percentile of 144 mohs-micrographic surgery providers in California.

See all mohs-micrographic surgery providers in California

Medicare billing

Part B allowed, 2024
$750,407
Medicare patients
848
Services billed
6,087

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab29$111,906
Isotretinoin20$3,741
Clobetasol Propionate45$2,824
Fluorouracil36$2,635
Ketoconazole82$1,534
Tacrolimus12$1,316
Triamcinolone Acetonide66$1,313
Tretinoin27$890
Desonide21$728
Minoxidil48$724
Gentamicin Sulfate19$636
Dutasteride15$522
Doxycycline Hyclate42$497
Mometasone Furoate27$491
Mupirocin57$421

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in San Diego

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →